Background: Unlike the tremendous progress made in atrial fibrillation ablation, the greatest unmet clinical need is for innovative ablation treatments for scar-related ventricular tachycardia (VT) – ...

Results at Six Months VCAS is a prospective, multicenter feasibility trial evaluating the safety and performance of the ...

Atrial fibrillation (AF) has traditionally been classified by episode duration, whereas rhythm control outcomes—via antiarrhythmic drugs or catheter ablation (CA)—have typically been evaluated using a ...

Jonathon Frye was sitting in his driveway when all of a sudden, his heart started to race. “It felt like I was running a ...

The company has now treated 500,000 patients with its pulsed field ablation system, in a competitive category poised for ...

Findings presented at the International VT Symposium and published simultaneously in Circulation. CARDIFF-BY-THE-SEA, Calif.

The atrial fibrillation market thrives on rising disease prevalence, technological advancements in AI and remote monitoring, and the need for innovative treatments. Companies harnessing these ...

Background Atrial fibrillation (AF) is linked to significant morbidity and mortality, with ischaemic stroke being a leading ...

Often referred to as a 'silent condition', atrial fibrillation can go unnoticed because its effect on the ventricles is often ...

Kardium announced today that it completed the first commercial procedures using its Globe pulsed field ablation (PFA) system.

Health First cardiologist Dr. Kevin Campbell, M.D., FACC, MBA, CPE, and Fleet Surgeon for the Eau Gallie Yacht Club, knows a steady rhythm matters ...

Atrial fibrillation (AF) is a predominant arrhythmia, posing challenges due to its association with increased morbidity, mortality, and healthcare resource ...